RNAi-based glyconanoparticles trigger apoptotic pathways for in vitro and in vivo enhanced cancer-cell killing
Resumen: Gold glyconanoparticles (GlycoNPs) are full of promise in areas like biomedicine, biotechnology and materials science due to their amazing physical, chemical and biological properties. Here, siRNA GlycoNPs (AuNP@PEG@Glucose@siRNA) in comparison with PEGylated GlycoNPs (AuNP@PEG@Glucose) were applied in vitro to a luciferase-CMT/167 adenocarcinoma cancer cell line and in vivo via intratracheal instillation directly into the lungs of B6 albino mice grafted with luciferase-CMT/167 adenocarcinoma cells. siRNA GlycoNPs but not PEGylated GlycoNPs induced the expression of pro-apoptotic proteins such as Fas/CD95 and caspases 3 and 9 in CMT/167 adenocarcinoma cells in a dose dependent manner, independent of the inflammatory response, evaluated by bronchoalveolar lavage cell counting. Moreover, in vivo pulmonary delivered siRNA GlycoNPs were capable of targeting c-Myc gene expression (a crucial regulator of cell proliferation and apoptosis) via in vivo RNAi in tumour tissue, leading to an ~80% reduction in tumour size without associated inflammation.
Idioma: Inglés
DOI: 10.1039/c4nr05742b
Año: 2015
Publicado en: NANOSCALE 7, 19 (2015), 9083-9091
ISSN: 2040-3364

Factor impacto JCR: 7.76 (2015)
Categ. JCR: MATERIALS SCIENCE, MULTIDISCIPLINARY rank: 23 / 270 = 0.085 (2015) - Q1 - T1
Categ. JCR: NANOSCIENCE & NANOTECHNOLOGY rank: 12 / 82 = 0.146 (2015) - Q1 - T1
Categ. JCR: CHEMISTRY, MULTIDISCIPLINARY rank: 18 / 162 = 0.111 (2015) - Q1 - T1
Categ. JCR: PHYSICS, APPLIED rank: 12 / 144 = 0.083 (2015) - Q1 - T1

Factor impacto SCIMAGO:

Tipo y forma: Article (Published version)
Área (Departamento): Química Orgánica (Departamento de Química Orgánica)
Exportado de SIDERAL (2017-05-04-09:46:44)

Este artículo se encuentra en las siguientes colecciones:
articulos > articulos-por-area > quimica_organica



 Notice créée le 2016-12-15, modifiée le 2017-05-04


Versión publicada:
 PDF
Évaluer ce document:

Rate this document:
1
2
3
 
(Pas encore évalué)